Certain in vitro studies have suggested that the downregulation of TUSC3 may induce the proliferation and migration of ovarian cancer cells, and increase the adhesion to the extracellular matrix.23, 24 Similar results were reported in prostate cancer.20 Here, TUSC3 is linked to prostate carcinoma.